title: [Antimutagenic and antiteratogenic properties of afobazole].
abstract: Experiments of mice and rats showed the ability of afobazole (1, 10, and 100 mg/kg, p.o.) upon single, 5-day combined, and 5-day preliminary administration to prevent or significantly decrease the clastogenic effects of the prooxidant agent dioxidine (100 and 300 mg/kg, i.p.) and the clastogenic and teratogenic effects of the alkylating agent cyclophosphamide (20 mg/kg, i.p.).
authors.forename: A D
authors.initials: AD
authors.lastname: Durnev
authors.forename: A K
authors.initials: AK
authors.lastname: Zhanataev
authors.forename: O V
authors.initials: OV
authors.lastname: Shreder
authors.forename: S B
authors.initials: SB
authors.lastname: Seredenin